A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus

Exclusion Criteria

• •2.1 In female subjects: pregnancy or breastfeeding period (self-reported)
• •2.2 HbA1c of \> 9.0% (based on last measurement by treating physician but not older than 120 days) Note: To be repeated at the study site if measurement is older than 120 days or not available
• •2.3 History of cardiovascular diseases
• •2.4 Irregular 12-lead ECG upon investigator's judgement
• •2.5 Medical history of epilepsy or other neurological disease associated with seizure events
• •2.6 Atypical skin condition (e.g., Hyperkeratosis, Hyperpigmentation) or presence of tattoos or scars in the measurement area (wrist) that could impair validity of measurement upon investigator's judgement
• •2.7 Known sensitivity to medical grade adhesives or other skin-related complications, which might influence the outcome
• •2.8 Not able to understand, write or read German
• •2.9 Participation in another investigation with an investigational drug within the 30 days preceding and during the present investigation
• •2.10 Enrolment of the PI, his/her family members, employees and other dependent persons